Technical Program | AIChE

AIChE will undertake a routine upgrade of our digital infrastructure between 12AM to 6AM ET on Tuesday April 22. During this time access to all services that require login or payment will be unavailable.

Technical Program 


Start Time End Time  
April 9, 2025 All Pacific Standard Time
    Day 1
1:00 PM 4:00 PM Registration
2:00 PM 2:10 PM Conference Introduction by Chairs: Raghu Shivappa, Takeda, &  Rubi Burlage, Merck
2:10 PM 2:50 PM

KEYNOTE: Accelerating Multi-Specific Zoo's, Jamie Moore, Gilead Sciences 

Read more

2:50 PM 3:20 PM Afternoon Coffee Break 
3:20 PM 4:00 PM

KEYNOTE: Investing in the future of Manufacturing: Practical Applications of AI and Analytics for Competitive Advantage, Bruce Lawler, MIT MIMO

Read more

4:00 PM 5:00 PM Poster Session and Cocktail Reception
     
Start Time End Time  
4/10/2025 All Pacific Standard Time
    Day 2
8:00 AM 4:00 PM Registration
8:00 AM 9:00 AM Breakfast
9:00 AM 9:10 AM Day 2 Welcome and Introduction by Chairs: Raghu Shivappa, Takeda, &  Rubi Burlage, Merck
9:10 AM 9:50 AM

KEYNOTE: Incorporation of Data Analytics and AI into the CMC lifecycle for Biopharma Products, Brendan Hughes, Independent Consultant

Read more

9:50 AM 10:00 AM Stretch Break
10:00 AM 1:05 PM Session 1: Artificial Intelligence (AI) and digital tools for accelerating Biopharmaceutical Process Development and Manufacturing;
10:00 AM 10:05 AM Introduction by Session Chairs: Trevor Swartz, Genentech
10:05 AM 10:25 AM

Building Teams and Setting Expectations in the Modern Era of AI/ML for Process Development, Jeremy Shaver, Pfizer

Read more

10:25 AM 10:45 AM

AI Machine Learning Digital Twins to Accelerate Biopharmaceutical Development at Amgen, Miguel Valderrama Gomez, Amgen

Read more

10:45 AM 11:05 AM

Accelerating Biopharmaceutical Process Development with Continuous Bioprocessing and Digital Twin, Ouwei Wang, Pow.bio

Read more

11:05 AM 11:35 AM Morning Coffee Break Sponsored by Takeda
11:35 AM 11:55 AM

Use of Digital Tools, Advanced Models, and ML/AI for Enhanced Process Understanding and Technology Transfers, Avik Sarkar, Merck

Read more

11:55 AM 12:15 PM

Predictive Capabilities & Risk Management: Transformation with Data & Digital, Sachin Mittal and Karthik Vaideeswaran, Merck

Read more

12:15 PM 12:35 PM

Sponsored Talk: Model-driven genetic design and bioprocess optimization across modalities, Alec Nielsen, Asimov 

Read more

12:35 PM 1:00 PM Q&A Panel Discussion
1:00 PM 1:05 PM Closing Remarks by Session Chair: Trevor Swartz, Genentech 
1:05 PM 2:20 PM Lunch: Roundtable on Progress and challenges of Digital Transformation – a critical step for AI-enabled Biopharmaceutical Development Moderated by Christian Airiau; Sponsored by Sanofi 
2:20 PM 6:25 PM Session 2: Formulation, Drug Product, and Drug Delivery
2:20 PM 2:25 PM Introduction by Session Chairs: Dana Andersen, Denali Therapeutics, & Cleo Salisbury, Genentech
2:25 PM 2:45 PM

Hypercon™ Microparticle Suspensions: a Novel Alternative for Subcutaneous Delivery of High Doses of Biotherapeutics, Victoria Sluzky, Elektrofi

Read more

2:45 PM 3:05 PM

High-Volume Subcutaneous Formulations Using Platform Excipients: Development and Launch, John Eschelbach, Genentech

Read more

3:05 PM 3:25 PM

Enabling Subcutaneous Delivery of Ultra-highly Concentrated Monoclonal Antibodies via Hydrogel Microparticles, Daniele Foresti, AcousticaBio 

Read more

3:25 PM 3:45 PM

Sponsored Talk: Subcutaneous Administration of Biologics: Formulation and Process Challenges, Parag Kolhe, Pfizer

Read more

3:45 PM 4:10 PM Q&A / Panel Discussion
4:10 PM 4:40 PM Afternoon Coffee Break Sponsored by Eli Lilly and Company
4:40 PM 5:00 PM

Designing Speed While Enabling Novel Modalities and Routes of Administration: Platforms & Standards, Sachin Mittal and Karthik Vaideeswaran, Merck

Read more

5:00 PM

5:20 PM

 Large Injections, Small Devices & Smart (RFID) Syringes, Adithiya Balasubramanian, Ten23

Read more

5:20 PM 5:40 PM

CMC Approaches for Acceleration of Manufacturing Capacity to Enable Launch of Beyfortus: A Case Study, Vinod Bulusu, AstraZeneca 

Read more

5:40 PM 6:00 PM

Sponsored Talk: CMC Acceleration through Integrated Development, Manufacturing, and Delivery, Sherry Gu, Wuxi Biologics

Read more

6:00 PM 6:25 PM Q&A / Panel Discussion
     
Start Time End Time  
4/11/2025 All Pacific Standard Time
    Day 3
8:00 AM 4:00 PM Registration
8:00 AM 9:00 AM Breakfast
9:00 AM 9:10 AM Day 3 Welcome and Introduction by Chairs: Raghu Shivappa, Takeda, &  Rubi Burlage, Merck
9:10 AM 9:50 AM

KEYNOTE: IMDELLTRA® – a DLL3 Targeting T Cell Engager for the Treatment of Small Cell Lung Cancer, Angela Coxon, Amgen

Read more

9:50 AM 10:00 AM Stretch Break
10:00 AM 11:00 AM Facilitated Panel Discussion 1: BioPhy: Opportunities for accelerating Biopharmaceutical Process Development and Manufacturing (David Latshaw) (Panelists: Bruce Lawler, MIT; Glen Bolton, Amgen; Stuti Agarwal, McKinsey;  Karthik Vaideeswaran, Merck)
11:00 AM 11:30 AM Morning Coffee Break
11:30 AM 12:30 PM Facilitated Panel Discussion 2: McKinsey: Acceleration Levers and AI for Biotherapeutics: (Stuti Agarwal) (Panelists: Terrence Dobrowsky, Takeda; Jennifer Pollard, BMS; Sachin Mittal, Merck)
12:30 PM 1:30 PM Lunch 
1:30 PM 4:50 PM Session 3: Business case for Sustainability
1:30 PM 1:35 PM Introduction by Session Chairs: Terrence Dobrowsky, Takeda, & William Clark, GSK
1:35 PM 1:55 PM

Advancing Amgen Ecovation™ through Innovative Process Development for Biologics, Kyle McElearney, Amgen

Read more

1:55 PM 2:15 PM

Ecodesign and Data Transparency: Keys to Reducing Bioprocessing Greenhouse Gas Emissions, Karl Britt, Cytiva

Read more

2:15 PM 2:35 PM

Advancing 3R Principle for Animal Welfare in Quality Control Testing, Lindsey Silva, Genentech

Read more

2:35 PM 3:05 PM Afternoon Coffee Break 
3:05 PM 3:25 PM

Business Case for Sustainability in Bioprocessing Via the Use of Combined Continuous Chromatography and on-Demand, Inline Buffer Blending Systems, Vinit Saxena, Sepragen Corporation

Read more

3:25 PM 3:45 PM

Measuring and achieving sustainability goals in biopharmaceutical manufacturing: A Case study comparing batch and integrated continuous biomanufacturing, Michael Coolbaugh, Sanofi 

Read more

3:45 PM 4:05 PM

Microbial Stem Cells: Asimica's Revolutionary Approach to Sustainable Biopharmaceutical Manufacturing, Nikolai Mushnikov, Asimica

Read more

4:05 PM 4:35 PM Q&A Panel Discussion
4:35 PM 4:50 PM Closing Remarks by the Chairs: Raghu Shivappa, Takeda, &  Rubi Burlage, Merck